Feature | Magnetic Resonance Imaging (MRI) | September 07, 2016

MRIs in Pregnancy Safe, But Gadolinium Scans May Raise Risk to Fetus

Study finds MRIs in first trimester of pregnancy were not associated with increased risk

Fetal MRI image on Philips Ingenia 1.5T

This study found MRI is safe by itself, but the use of gadolinium contrast may be a factor involved with an array of issues that impact the fetus and young children after birth.  

Fetal MRI image slider

September 7, 2016 — In an analysis that included more than 1.4 million births, exposure to magnetic resonance imaging (MRI) during the first trimester of pregnancy compared with nonexposure was not associated with increased risk of harm to the fetus or in early childhood. However, data suggests gadolinium contrast enhanced MRI scans at any time during pregnancy may be associated with an increased risk of a broad set of rheumatological, inflammatory or skin conditions and, possibly, for stillbirth or neonatal death, according to a study appearing in the Sept. 6, 2016, issue of Journal of the American Medical Association (JAMA).[1]

Concern has been expressed about the safety of MRI exposure in the first trimester of pregnancy due to the heating of sensitive tissues by radiofrequency fields and exposure to the loud acoustic environment. When indicated, MRI's diagnostic accuracy is improved with gadolinium, an intravenous contrast agent. Fetal safety of MRI during the first trimester of pregnancy or with gadolinium enhancement at any time of pregnancy is unknown. While MRI is generally thought to be safe for the fetus in the second or third trimesters of pregnancy, there were no prior controlled studies on its safety in the first trimester, when the fetus forms its major organs and body structures.

 

Watch the VIDEO "MRI Gadolinium Contrast Retention in the Brain."

 

To inform clinical guidelines for MRIs on pregnant women, Joel G. Ray, M.D., M.Sc., FRCPC, of St. Michael's Hospital and the Institute for Clinical Evaluative Sciences, Toronto, and colleagues used health data housed at the Institute for Clinical Evaluative Sciences to examine records of more than 1.4 million births in Ontario from 2003-2015. They compared women who had first-trimester MRIs with those who had not, and also followed their children up to age 4. 

In pregnancies that lasted a minimum of 21 gestational weeks, 1 in 250 had an MRI in pregnancy, including 1 in 1,200 in the first trimester and 1 in 3,000 with gadolinium contrast. Maternal MRI in the first trimester was not associated with a higher risk of stillbirth or neonatal death, congenital anomalies, neoplasm or hearing loss.

"Having an MRI at the earliest stages of pregnancy does not seem to alter the development of the fetus," Ray said.

However, exposure to gadolinium-enhanced MRI at any gestation was not associated with a greater risk of congenital anomalies. Although a nephrogenic systemic fibrosis-like outcome was extremely rare, gadolinium-enhanced MRI was associated with an increased risk for a non-specific outcome of any rheumatological, inflammatory or infiltrative skin condition up to age 4 years, and for stillbirth or neonatal death, although there were just seven events in the gadolinium MRI group.

"The current findings inform published recommendations about the safety of MRI in the first trimester of pregnancy," the authors wrote. "Until further studies are done, these findings suggest that gadolinium contrast should be avoided during pregnancy."

Read the article “Gadolinium May Remain in Brain after Contrast MRI.” 

Even though the actual number of stillbirths was low (one in 50), and the outcome of a skin or rheumatological condition was very broadly defined, Ray said the results support clinical guidelines to avoid giving pregnant women gadolinium unless strongly indicated.

The current study did not include specific information as to why the women received an MRI, or whether they knew they were pregnant at the time. But the study did track the specialty of the physician ordering the MRI: 44 percent were family physicians, suggesting the MRI may have been booked prior to a woman having conceived. The other common specialty was a neurologist or neurosurgeon, suggesting that some women were investigated for headaches or spinal disc issues.

For more information http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.12126

 

Related Gadolinium Safety Concern Articles

Gadolinium May Remain in Brain after Contrast MRI

ACR Manual on Contrast Media Addresses FDA Gadolinium Safety Concerns

Study Finds No Association Between Gadolinium Contrast and Nervous System Disorder

Even High Doses of Gadolinium-Based Contrast Agents Doesn't Cause NSF

Reference: 

1. Joel G. Ray, Marian J. Vermeulen, Aditya Bharatha, et al. “Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes.” JAMA. 2016;316(9):952-961. doi:10.1001/jama.2016.12126.

Related Content

Guerbet Signs Agreement With Icometrix for Exclusive Distribution of Icobrain
News | Neuro Imaging | October 16, 2019
Guerbet announced it has signed an exclusive agreement with Icometrix for the distribution in France, Italy and Brazil...
Subtle Medical Receives FDA 510(k) Clearance for AI-powered SubtleMR
Technology | Artificial Intelligence | October 16, 2019
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtleMR. SubtleMR...
Using Compressed SENSE for faster MRI scans, healthcare providers can transform their radiology workflow.

Using Compressed SENSE for faster MRI scans, healthcare providers can transform their radiology workflow.

Sponsored Content | Case Study | Magnetic Resonance Imaging (MRI) | October 16, 2019
Since the introduction of magnetic resonan...
Feature | Breast Imaging | October 16, 2019 | By Jeff Zagoudis
On Jan. 1, 2017, the U.S.
Genia Sutton, intGenia Sutton, interim director of radiology

Genia Sutton, interim director of radiology, has seen the benefit to patients. “Five minutes is a lot of time if you are thinking you may have breast cancer,” she said. “Now, technologists aren’t as rushed. They can give a more personal touch because they can spend more time with their patients.”

Sponsored Content | Case Study | Mammography | October 10, 2019
When Cullman Regional Medical Center in Alabama decided to
Canon Medical Receives FDA Clearance for Vantage Orian 1.5T MRI

Canon Medical Receives FDA Clearance for Vantage Orian 1.5T MRI

Feature | Magnetic Resonance Imaging (MRI) | October 09, 2019 | By Jeff Zagoudis
Sponsored Content | Whitepapers | Clinical Trials | October 09, 2019
A 2019 N G PX REPORT
Patient Treatments With ViewRay's MRIdian Linac Begin in New England
News | Image Guided Radiation Therapy (IGRT) | October 08, 2019
ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac...
Hologic, Inc.’s Company’s Chairman, President and Chief Executive Officer Steve MacMillan, joined a number of employees to ring the Nasdaq Opening Bell for the 14th consecutive year on Oct. 2
News | Women's Health | October 04, 2019
Hologic, Inc.’s Company’s Chairman, President and Chief Executive Officer ...
Breast cancer awareness month is October
News | Clinical Case Studies | October 03, 2019
A decades-long decline in the breast cancer death rate continues, but has begun to slow in recent years, while breast